Becton, Dickinson and Company v. Cytek Biosciences Inc.
Opinion
Trial Court Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA 6 BECTON, DICKINSON AND Case No. 18-cv-00933-MMC
COMPANY,
8 Plaintiff, ORDER GRANTING MOTION TO DISMISS; AFFORDING LEAVE TO v. AMEND 10 CYTEK BIOSCIENCES INC., et al., 11 Defendants. 12 Before the Court is defendant/counterclaimant Cytek Biosciences Inc.’s (“Cytek”) motion, filed January 9, 2020, to dismiss the Fifth and Eighth Claims for Relief asserted against it in plaintiff/counterdefendant Becton, Dickinson and Company’s (“BD”) Second Amended Complaint. BD has filed opposition, to which Cytek has replied. Having read and considered the papers filed in support of and in opposition to the motion, the Court rules as follows.1 BACKGROUND BD is a “medical technology company” that “manufactures and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products,” including flow cytometers. (See SAC ¶ 2.) Cytek is a company that “service[s] and 23 …